HT
IART icon

Headlands Technologies’s Integra LifeSciences IART Stock Holding History

Headlands Technologies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Sell
21,462
-36,173
-63% -$506K 0.04% 476
2026
Q1 		$543K Buy
57,635
+7,477
+15% +$82.1K 0.06% 339
2025
Q4 		$623K Buy
50,158
+17,463
+53% +$232K 0.05% 362
2025
Q3 		$469K Buy
32,695
+18,742
+134% +$257K 0.04% 377
2025
Q2 		$171K Sell
13,953
-764
-5% -$11.1K 0.02% 516
2025
Q1 		$324K Buy
14,717
+2,783
+23% +$65.4K 0.04% 366
2024
Q4 		$271K Buy
+11,934
New +$260K 0.03% 457
2024
Q3 		– Sell
-26,592
Closed -$775K – 1342
2024
Q2 		$775K Buy
26,592
+21,828
+458% +$647K 0.08% 204
2024
Q1 		$169K Buy
4,764
+1,677
+54% +$67.1K 0.04% 410
2023
Q4 		$134K Sell
3,087
-9,862
-76% -$388K 0.04% 339
2023
Q3 		$495K Buy
12,949
+6,163
+91% +$259K 0.24% 95
2023
Q2 		$279K Buy
+6,786
New +$327K 0.09% 236

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Headlands Technologies's IART Position: Q2 2026 in Review

Headlands Technologies reduced its Integra LifeSciences (IART) stake by 63% in Q2 2026, selling an estimated $506K and leaving 21,462 shares worth $385K. The position accounts for 0.04% of the portfolio, ranked #476.

Headlands Technologies first reported a position in IART in Q2 2023 and has held it in 12 quarters since. The position peaked at $775K in Q2 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Headlands Technologies held 21,462 shares of Integra LifeSciences worth $385K as of Q2 2026.
  • Headlands Technologies sold 36,173 Integra LifeSciences shares in Q2 2026, an estimated $506K.
  • Integra LifeSciences made up 0.04% of Headlands Technologies's portfolio in Q2 2026, its #476 holding.
  • Headlands Technologies first reported a position in Integra LifeSciences in Q2 2023 and has held it in 12 quarters since.
  • Headlands Technologies's Integra LifeSciences position peaked at $775K in Q2 2024.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.